RICE HALL JAMES & ASSOCIATES, LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$51,000
-26.1%
29,511
-4.3%
0.00%
-25.0%
Q2 2015$69,000
+4.5%
30,842
-9.4%
0.00%0.0%
Q1 2015$66,000
+1.5%
34,052
+39.4%
0.00%0.0%
Q4 2014$65,000
-33.7%
24,422
-25.0%
0.00%
-42.9%
Q3 2014$98,000
-25.8%
32,567
+1.3%
0.01%
-22.2%
Q2 2014$132,000
-3.6%
32,164
+1.5%
0.01%
-10.0%
Q1 2014$137,000
-13.8%
31,701
+4.2%
0.01%
-9.1%
Q4 2013$159,00030,4160.01%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders